{
  "subset": "contraindication",
  "disease": "Severe hypertriglyceridaemia",
  "relation": "contraindication",
  "gold_drugs": [
    "akr-963",
    "ari-3037mo",
    "aro-apoc3",
    "capre",
    "cat-2003",
    "conservative treatment",
    "corn oil",
    "dr10624 injection",
    "epanova",
    "epanova () + lovaza ()",
    "ethyl icosapentate",
    "evinacumab",
    "fenofibrate",
    "fish oil",
    "gemcabene",
    "insulin",
    "isis apoc-iii rx",
    "k-877",
    "lcq908",
    "lovaza",
    "mat9001",
    "metformin eicosapentaenoate",
    "metformin hcl + vascepa",
    "mibavademab",
    "olezarsen",
    "olive oil",
    "omefas",
    "omega-3-acid ethyl esters 90 soft capsules",
    "pegozafermin",
    "placebo",
    "placebo of fenofibrate",
    "placebo of fish oil",
    "placebo of lcq908",
    "plozasiran",
    "plozasiran injection",
    "sc401b 2 capsules",
    "sc401b 4 capsules",
    "sc401b 6 capsules",
    "sterile normal saline (0.9% nacl)"
  ],
  "seeds_initial": [
    "Fenofibrate",
    "Gemfibrozil",
    "Niacin",
    "Omega-3 fatty acids",
    "Fibrates",
    "Estrogen",
    "Thiazide diuretics",
    "Beta-blockers",
    "Propofol",
    "Glucocorticoids",
    "Aminophylline",
    "Isotretinoin"
  ],
  "seed_history": [
    [
      "Fenofibrate",
      "Gemfibrozil",
      "Niacin",
      "Omega-3 fatty acids",
      "Fibrates",
      "Estrogen",
      "Thiazide diuretics",
      "Beta-blockers",
      "Propofol",
      "Glucocorticoids",
      "Aminophylline",
      "Isotretinoin"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.12,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "潜在的降脂机制与高甘油三酯血症的关联性较弱",
          "可能的安全性风险影响其有效性"
        ],
        "caveats": [
          "缺乏有力的直接证据支持其用于重度高甘油三酯血症的应用"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.12,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "尽管有降脂作用，但安全性问题显著"
        ],
        "caveats": [
          "与重度高甘油三酯血症的直接相关性不足"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "score": 0.12,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "潜在的脂质调节机制尚需明确"
        ],
        "caveats": [
          "安全性风险及疗效的不确定性"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug → Lipid Metabolism → Lipid Regulation Pathway → Severe Hypertriglyceridaemia",
          "reason": "机制链条缺失，安全性问题加剧"
        }
      ],
      "remaining_gaps": [
        "针对每个候选药物缺少有效的支持性证据与临床关联"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [],
          "impact_summary": "未能补齐机制链，所有候选均未有效支撑"
        }
      ],
      "lessons": [
        "注重候选药物的机制证据与安全性评估，尤其是与疗效直接相关的临床数据"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "提供更强有力的临床证据支持降低高甘油三酯血症的潜力"
      },
      {
        "role": "Skeptic",
        "patch": "明确标出潜在的不良结果和安全性风险"
      }
    ],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Severe hypertriglyceridaemia'. Return only names.\n\n# Heuristics:\n- When 高甘油三酯表型: then 特别考虑与不良反应及对疗效的综合影响。\n- When 评估药物安全性: then 需系统检验现有临床数据以增强信服力。"
}